This retrospective-prospective study evaluated whether a deep learning-based MRI reconstruction algorithm can preserve diagnostic quality in brain MRI scans accelerated up to fourfold, using both public and prospective clinical data. The study included 18 healthy volunteers (scans acquired at 3T, January 2024-March 2025), as well as selected fastMRI public datasets with diverse pathologies. Phase-encoding-undersampled 2D/3D T1, T2, and FLAIR sequences were reconstructed with DeepFoqus-Accelerate and compared with standard-of-care (SOC). Three board-certified neuroradiologists and two MRI technologists independently reviewed 36 paired SOC/AI reconstructions from both datasets using a 5-point Likert scale, while quantitative similarity was assessed for 408 scans and 1224 datasets using Structural Similarity Index (SSIM), Peak Signal-to-Noise Ratio (PSNR), and Haar wavelet-based Perceptual Similarity Index (HaarPSI). No AI-reconstructed scan scored below 3 (minimally acceptable), and 95% scored $\geq 4$. Mean SSIM was 0.95 $\pm$ 0.03 (90% cases >0.90), PSNR >41.0 dB, and HaarPSI >0.94. Inter-rater agreement was slight to moderate. Rare artifacts did not affect diagnostic interpretation. These findings demonstrate that DeepFoqus-Accelerate enables robust fourfold brain MRI acceleration with 75% reduced scan time, while preserving diagnostic image quality and supporting improved workflow efficiency.

Conventional computed tomography (CT) lacks the ability to capture dynamic, weight-bearing joint motion. Functional evaluation, particularly after surgical intervention, requires four-dimensional (4D) imaging, but current methods are limited by excessive radiation exposure or incomplete spatial information from 2D techniques. We propose an integrated 4D joint analysis platform that combines: (1) a dual robotic arm cone-beam CT (CBCT) system with a programmable, gantry-free trajectory optimized for upright scanning; (2) a hybrid imaging pipeline that fuses static 3D CBCT with dynamic 2D X-rays using deep learning-based preprocessing, 3D-2D projection, and iterative optimization; and (3) a clinically validated framework for quantitative kinematic assessment. In simulation studies, the method achieved sub-voxel accuracy (0.235 mm) with a 99.18 percent success rate, outperforming conventional and state-of-the-art registration approaches. Clinical evaluation further demonstrated accurate quantification of tibial plateau motion and medial-lateral variance in post-total knee arthroplasty (TKA) patients. This 4D CBCT platform enables fast, accurate, and low-dose dynamic joint imaging, offering new opportunities for biomechanical research, precision diagnostics, and personalized orthopedic care.

Background: The aim of this study was to develop and evaluate a deep learning-based automated segmentation method for hepatic anatomy (i.e., parenchyma, tumors, portal vein, hepatic vein and biliary tree) from the hepatobiliary phase of gadoxetic acid-enhanced MRI. This method should ease the clinical workflow of preoperative planning. Methods: Manual segmentation was performed on hepatobiliary phase MRI scans from 90 consecutive patients who underwent liver surgery between January 2020 and October 2023. A deep learning network (nnU-Net v1) was trained on 72 patients with an extra focus on thin structures and topography preservation. Performance was evaluated on an 18-patient test set by comparing automated and manual segmentations using Dice similarity coefficient (DSC). Following clinical integration, 10 segmentations (assessment dataset) were generated using the network and manually refined for clinical use to quantify required adjustments using DSC. Results: In the test set, DSCs were 0.97+/-0.01 for liver parenchyma, 0.80+/-0.04 for hepatic vein, 0.79+/-0.07 for biliary tree, 0.77+/-0.17 for tumors, and 0.74+/-0.06 for portal vein. Average tumor detection rate was 76.6+/-24.1%, with a median of one false-positive per patient. The assessment dataset showed minor adjustments were required for clinical use of the 3D models, with high DSCs for parenchyma (1.00+/-0.00), portal vein (0.98+/-0.01) and hepatic vein (0.95+/-0.07). Tumor segmentation exhibited greater variability (DSC 0.80+/-0.27). During prospective clinical use, the model detected three additional tumors initially missed by radiologists. Conclusions: The proposed nnU-Net-based segmentation method enables accurate and automated delineation of hepatic anatomy. This enables 3D planning to be applied efficiently as a standard-of-care for every patient undergoing liver surgery.

Scoliosis affects roughly 2 to 4 percent of adolescents, and treatment decisions depend on precise Cobb angle measurement. Manual assessment is time consuming and subject to inter observer variation. We conducted a retrospective, multi centre evaluation of a fully automated deep learning software (Carebot AI Bones, Spine Measurement functionality; Carebot s.r.o.) on 103 standing anteroposterior whole spine radiographs collected from ten hospitals. Two musculoskeletal radiologists independently measured each study and served as reference readers. Agreement between the AI and each radiologist was assessed with Bland Altman analysis, mean absolute error (MAE), root mean squared error (RMSE), Pearson correlation coefficient, and Cohen kappa for four grade severity classification. Against Radiologist 1 the AI achieved an MAE of 3.89 degrees (RMSE 4.77 degrees) with a bias of 0.70 degrees and limits of agreement from minus 8.59 to plus 9.99 degrees. Against Radiologist 2 the AI achieved an MAE of 3.90 degrees (RMSE 5.68 degrees) with a bias of 2.14 degrees and limits from minus 8.23 to plus 12.50 degrees. Pearson correlations were r equals 0.906 and r equals 0.880 (inter reader r equals 0.928), while Cohen kappa for severity grading reached 0.51 and 0.64 (inter reader kappa 0.59). These results demonstrate that the proposed software reproduces expert level Cobb angle measurements and categorical grading across multiple centres, suggesting its utility for streamlining scoliosis reporting and triage in clinical workflows.

Traditional echocardiographic parameters such as ejection fraction (EF) and global longitudinal strain (GLS) have limitations in the early detection of cardiac dysfunction. EF often remains normal despite underlying pathology, and GLS is influenced by load conditions and vendor variability. There is a growing need for reproducible, interpretable, and operator-independent parameters that capture subtle and global cardiac functional alterations. We introduce the Acoustic Index, a novel AI-derived echocardiographic parameter designed to quantify cardiac dysfunction from standard ultrasound views. The model combines Extended Dynamic Mode Decomposition (EDMD) based on Koopman operator theory with a hybrid neural network that incorporates clinical metadata. Spatiotemporal dynamics are extracted from echocardiographic sequences to identify coherent motion patterns. These are weighted via attention mechanisms and fused with clinical data using manifold learning, resulting in a continuous score from 0 (low risk) to 1 (high risk). In a prospective cohort of 736 patients, encompassing various cardiac pathologies and normal controls, the Acoustic Index achieved an area under the curve (AUC) of 0.89 in an independent test set. Cross-validation across five folds confirmed the robustness of the model, showing that both sensitivity and specificity exceeded 0.8 when evaluated on independent data. Threshold-based analysis demonstrated stable trade-offs between sensitivity and specificity, with optimal discrimination near this threshold. The Acoustic Index represents a physics-informed, interpretable AI biomarker for cardiac function. It shows promise as a scalable, vendor-independent tool for early detection, triage, and longitudinal monitoring. Future directions include external validation, longitudinal studies, and adaptation to disease-specific classifiers.

Background: Conventional cardiovascular magnetic resonance (CMR) in paediatric and congenital heart disease uses 2D, breath-hold, balanced steady state free precession (bSSFP) cine imaging for assessment of function and cardiac-gated, respiratory-navigated, static 3D bSSFP whole-heart imaging for anatomical assessment. Our aim is to concatenate a stack 2D free-breathing real-time cines and use Deep Learning (DL) to create an isotropic a fully segmented 3D cine dataset from these images. Methods: Four DL models were trained on open-source data that performed: a) Interslice contrast correction; b) Interslice respiratory motion correction; c) Super-resolution (slice direction); and d) Segmentation of right and left atria and ventricles (RA, LA, RV, and LV), thoracic aorta (Ao) and pulmonary arteries (PA). In 10 patients undergoing routine cardiovascular examination, our method was validated on prospectively acquired sagittal stacks of real-time cine images. Quantitative metrics (ventricular volumes and vessel diameters) and image quality of the 3D cines were compared to conventional breath hold cine and whole heart imaging. Results: All real-time data were successfully transformed into 3D cines with a total post-processing time of <1 min in all cases. There were no significant biases in any LV or RV metrics with reasonable limits of agreement and correlation. There is also reasonable agreement for all vessel diameters, although there was a small but significant overestimation of RPA diameter. Conclusion: We have demonstrated the potential of creating a 3D-cine data from concatenated 2D real-time cine images using a series of DL models. Our method has short acquisition and reconstruction times with fully segmented data being available within 2 minutes. The good agreement with conventional imaging suggests that our method could help to significantly speed up CMR in clinical practice.

This study presents a deep learning system for breast cancer detection in mammography, developed using a modified EfficientNetV2 architecture with enhanced attention mechanisms. The model was trained on mammograms from a major Thai medical center and validated on three distinct datasets: an in-domain test set (9,421 cases), a biopsy-confirmed set (883 cases), and an out-of-domain generalizability set (761 cases) collected from two different hospitals. For cancer detection, the model achieved AUROCs of 0.89, 0.96, and 0.94 on the respective datasets. The system's lesion localization capability, evaluated using metrics including Lesion Localization Fraction (LLF) and Non-Lesion Localization Fraction (NLF), demonstrated robust performance in identifying suspicious regions. Clinical validation through concordance tests showed strong agreement with radiologists: 83.5% classification and 84.0% localization concordance for biopsy-confirmed cases, and 78.1% classification and 79.6% localization concordance for out-of-domain cases. Expert radiologists' acceptance rate also averaged 96.7% for biopsy-confirmed cases, and 89.3% for out-of-domain cases. The system achieved a System Usability Scale score of 74.17 for source hospital, and 69.20 for validation hospitals, indicating good clinical acceptance. These results demonstrate the model's effectiveness in assisting mammogram interpretation, with the potential to enhance breast cancer screening workflows in clinical practice.